🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The objective of this study is to assess the efficacy, safety, and tolerabi...
Status
Completed
Location
CYS-003 Investigational Site
Start Date
2017-10-19
Trial ID
NCT03292809
Treatments Being Tested
In this preliminary study, we propose that the intraepidermic injection of ...
Status
Completed
Location
Entertainment Area, Badr City, Cairo, Egypt
Start Date
2018-01-03
Trial ID
NCT07043985
Treatments Being Tested
This study is designed to optimize calcineurin immunosuppressive regimens a...
Status
Completed
Location
Brody School of Medicine at East Carolina University
Start Date
2003-08
Trial ID
NCT00905515
Treatments Being Tested
The purpose of this retrospective observational cohort study is to assess p...
Status
Active Not Recruiting
Location
OptumInsight Life Sciences Inc
Start Date
2024-08-26
Trial ID
NCT06126835
Treatments Being Tested
the cyclosporine showed efficacy in many immune cytopenic diseases in the l...
Status
Recruiting
Location
Assiut university hospital
Start Date
2021-10-20
Trial ID
NCT05057468
Treatments Being Tested
Switching to acoltremon 0.003% will significantly improve the signs and sym...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-12-01
Trial ID
NCT07267299
Treatments Being Tested
This was a pivotal trial to determine whether LX201 reduces the likelihood ...
Status
Terminated
Location
Cornea Consultants of Arizona
Start Date
2007-04
Trial ID
NCT00447187
Dyskeratosis congenita is a disease that affects numerous parts of the body...
Status
Active Not Recruiting
Location
University of Chicago
Start Date
2012-07
Trial ID
NCT01659606
Treatments Being Tested
This study was designed to evaluate the renal function comparing Certican b...
Status
Completed
Location
Novartis Investigative Site
Start Date
2012-12-27
Trial ID
NCT01843348
Monoclonal antibodies, such as yttrium Y 90 ibritumomab tiuxetan, can block...
Status
Completed
Location
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
Start Date
2004-06
Trial ID
NCT00119392